(Q34033135)

30 July 2017

1 reference

title

NF-kappa B and HIV: linking viral and immune activation (English)

1 reference

30 July 2017

1 reference

Rabson AB

1

1 reference

PubMed ID

10987091

30 July 2017

Lin HC

series ordinal

2

1 reference

PubMed ID

10987091

30 July 2017

language of work or name

1 reference

1 January 2000

1 reference

30 July 2017

Advances in Pharmacology

1 reference

30 July 2017

48

1 reference

30 July 2017

161-207

1 reference

Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-induced lymphocyte proliferation

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Ikappakappa mediates NF-kappaB activation in human immunodeficiency virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Mechanisms of HIV-1 latency

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Application of latent HIV-1 infected cellular models to therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Inhibition of tumor necrosis factor by curcumin, a phytochemical

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

NF-kappaB protects HIV-1-infected myeloid cells from apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

A DNA-binding protein containing two widely separated zinc finger motifs that recognize the same DNA sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Unique lentivirus--host interactions: SIVsmmPBj14 infection of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Upregulation of cyclin T1/CDK9 complexes during T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kappaB-dependent transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Induction of AIDS by simian immunodeficiency virus lacking NF-kappaB and SP1 binding elements

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Structure of an IkappaBalpha/NF-kappaB complex

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Antioxidant therapy and HIV infection: 1998

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Nuclear factor kappa B: important transcription factor and therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Requirement of RSF and FACT for transcription of chromatin templates in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Activation of SV40 genome by 72-base pair tandem repeats of Moloney sarcoma virus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Distinct domains of IkappaBalpha regulate c-Rel in the cytoplasm and in the nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Signal transduction through NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Regulation of the mouse alpha A-crystallin gene: isolation of a cDNA encoding a protein that binds to a cis sequence motif shared with the major histocompatibility complex class I gene and other genes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Basal transcription factors TBP and TFIIB and the viral coactivator E1A 13S bind with distinct affinities and kinetics to the transactivation domain of NF-kappaB p65.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Transcription factors of the NFAT family: regulation and function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Identification and characterization of an IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Angiotensinogen gene-inducible enhancer-binding protein 1, a member of a new family of large nuclear proteins that recognize nuclear factor kappa B-binding sites through a zinc finger motif

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Long terminal repeat and nef gene variants of human immunodeficiency virus type 1 in perinatally infected long-term survivors and rapid progressors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Histone acetyltransferases regulate HIV-1 enhancer activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Antioxidants inhibit stimulation of HIV transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Regulation of HIV expression by viral genes and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

No association of HIV type 1 long terminal repeat sequence pattern with long-term nonprogression and in vivo viral replication levels in European subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Hexamethylene bisacetamide activates the human immunodeficiency virus type 1 provirus by an NF-kappa B-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Identification of a signal for rapid export of proteins from the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

In vitro chromatin assembly of the HIV-1 promoter. ATP-dependent polar repositioning of nucleosomes by Sp1 and NFkappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Alteration of nucleosome structure as a mechanism of transcriptional regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

Simian immunodeficiency viruses containing mutations in the long terminal repeat NF-kappa B or Sp1 binding sites replicate efficiently in T cells and PHA-stimulated PBMCs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948006-3

7 January 2021

10.1016/S1054-3589(00)48006-3

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10987091